Our CEO, Dr. Gabriel Makdah, travelled to Lyon to pitch on stage. We came home in first place.
Each year, the Innovation Contest at Medi'Nov Connection recognises a start-up and its medical device, singling out the work most likely to shape the future of medtech. The 2026 edition, held on 1 and 2 July at the Lyon Convention Centre, brought together manufacturers, hospitals, clinicians, investors, and regulatory specialists from across the French medical device sector.
We are proud to stand first among so many strong projects, and to see patient-centred brain-computer interfaces recognised at the forefront of medtech.
What we are building
Our mission is to restore speech and digital autonomy to people living with severe paralysis. We do it with a minimally invasive brain implant that rests on the dura, the brain's protective membrane, without ever penetrating the tissue beneath it.
That distinction matters. Conventional implants push electrodes into the cortex itself, which brings a heavier surgery and a device whose performance degrades as the brain reacts to it. Staying above the membrane means a simpler operation and a device designed to last.
For someone who has lost movement and speech, technology that gives back communication and control is not a convenience. It is the return of self.
Thank you
Our thanks to the Medi'Nov Connection organising team for an excellent event, and to the jury: Lionel Monteiro (CIC), Olivier Chabanon (Bpifrance), and Hugo Servanton (France Biotech); for their belief in what we are building.
This recognition belongs to our whole team, and to the people living with paralysis who guide our work every day. We build with them, not just for them.